![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
F.i.s. - Fabbrica Italiana Sintetici S.p.a. Montecchio Maggiore It, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Propofol, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2004-313 - Rev 01
This Chemical Type CEP, issued on March 01, 2017, remains in force until February 13, 2023, ensuring its reliability within the pharmaceutical industry.
Substance Number 1558 associated with this CEP further emphasizes